Overall, our findings suggest a potential diagnostic and prognostic role for p16 immunoreactivity in UCA, consistent with previous studies that have reported its clinical relevance in HPV-associated cervical adenocarcinomas [51,52]. The gene discussed is CDKN2A; the disease is cervical adenocarcinoma.